arthritis drug

StreetInsider.com Notable ETF Movers: HIGHER:

• iPath DJ AIG Platinum TR Sub-Idx ETN (NYSE: PGM) Up 6.10%, as platinum futures are down about 1.4%.
  
  Investors might be looking for exposure in a different metals other than gold and silver, as many commodities have been having a good year so far.
• Health Care Select Sector SPDR (NYSE: XLV) up about 0.50%.
  
  Major holdings include Johnson & Johnson (NYSE: JNJ), Bristol Meyers (NYSE: BMY), and Pfizer (NYSE: PFE).
  
  Bristol Meyers announced a deal to develop Alder's arthritis drug today.

The Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc. and Biogen Idec said Saturday.